MedPlus Health Services Limited IPO: Issue Price, Listing Gain and Share Price Now
MedPlus Health Services Limited listed on 23-Dec-2021 at ₹1,120.85 against an issue price of ₹796 , a listing gain of +40.81%. It last traded at ₹656.8. This page is the record of that issue and what has happened to it since — reported figures only.
MedPlus Health Services Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹796 |
| Listing price (listing-day close) | ₹1,120.85 |
| Listing gain | +40.81% |
| Price now | ₹656.8 |
| Change from issue price | -17.49% |
| Change from listing-day close | -41.40% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
MedPlus Health Services Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹796 |
| Issue size | ₹1,398.29 Cr |
| Fresh issue | ₹600.31 Cr |
| Offer for sale | ₹797.98 Cr |
| Issue opened | 13-Dec-2021 |
| Issue closed | 15-Dec-2021 |
| Listed on | 23-Dec-2021 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Axis Capital (left lead) |
How the MedPlus Health Services Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 111.90x |
| NII | 85.33x |
| Retail | 5.24x |
| Total | 52.59x |
MedPlus Health Services Limited today
| Figure | Value |
|---|---|
| Market capitalisation | ₹7,878 Cr |
| Trailing P/E | 37.40x |
| Return on capital employed | 12.6% |
| Return on equity | 11.6% |
| 52-week high | ₹1,022 |
| 52-week low | ₹647 |
| Sector | Pharmacy Retail |
Fundamentals are as of the desk's last harvest and move with the market.
- MedPlus Health Services Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.